Wegovy and Mounjaro users warned over contraceptive pill guidance
Wegovy and Mounjaro users warned over pill guidance

Women taking Mounjaro alongside the contraceptive pill are advised to use a barrier method for four weeks after starting treatment and for four weeks after each dose increase, according to medication expert Dr Kate Bunyan, medical director at heart check test kit provider PocDoc.

Dr Bunyan said weight loss medications such as Mounjaro and Wegovy have become an important development in obesity management, offering significant benefits for people who are clinically eligible. However, she cautioned that they must be used properly, particularly by women using the pill.

Why the pill may be affected

Dr Bunyan explained that Mounjaro slows how quickly the stomach empties, which can reduce how well the pill is absorbed. Vomiting or diarrhoea, which are common side effects, can have a similar effect.

Women taking Mounjaro who use the pill (combined or progestogen-only) are advised to use a barrier method as well for four weeks after starting treatment and for four weeks after each dose increase, or to switch to a non-oral method. Barrier methods are physical ways to prevent conception, such as condoms or cervical caps.

Pregnancy planning advice

Women who are planning a pregnancy should talk to their healthcare professional first. Dr Bunyan said weight loss treatments such as Mounjaro and Wegovy aren't recommended during pregnancy because they haven't been tested in pregnant women in clinical trials, so there is no evidence to know they're safe.

Each medicine needs to be stopped for a set period before trying to conceive, and that period differs between treatments.

Finding official guidance

Dr Bunyan advised that the best starting point is always the healthcare professional prescribing the medication, who can give advice tailored to individual health needs and treatment plan. People should also read the patient information leaflet supplied with their medication, as recommendations vary between treatments.

Other official sources of information include the NHS and the Medicines and Healthcare products Regulatory Agency (MHRA), which are reliable sources providing guidance on how different treatments work, how they should be taken and any updates to prescribing advice. The electronic medicines compendium (emc) is another useful resource with detailed information about medicines licensed in the UK. If buying online, users should check that the pharmacy is registered with the General Pharmaceutical Council (GPhC).